KCNA1 and glioblastoma: Using a set of KCNA1 inhibitors, we demonstrated that pharmacological targeting of KCNA1 significantly suppressed GBMINV cell invasion in vitro, blocked GBM invasion in vivo and prolonged animal survival times in a highly invasive pGBM model.